CNTB
Connect Biopharma·NASDAQ
--
--(--)
--
--(--)
4.19 / 10
Netural
CNTB's fundamental status is rated Neutral. Key strengths include a healthy Interest coverage ratio (EBIT/Interest expense) of 15.48%, indicating good debt servicing capacity, and positive Revenue-MV suggesting revenue outperforms market value peers. However, significant weaknesses are evident: Days sales outstanding are extremely high at 1700.16, pointing to slow receivable collection, and both Total operating revenue and Operating revenue show a sharp year-over-year decline of -99.75%, signaling deteriorating sales. These mixed fundamentals justify a selective appraisal rather than an outright recommendation.
Analysis Checks(8/10)
Revenue-MV
Value-6.96
Score3/3
Weight20.17%
1M Return10.54%
Value-6.96
Score3/3
Weight20.17%
1M Return10.54%
Days sales outstanding
Value1700.16
Score1/3
Weight-2.22%
1M Return-1.57%
Value1700.16
Score1/3
Weight-2.22%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight16.10%
1M Return8.45%
Value-0.17
Score2/3
Weight16.10%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.61%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.61%
1M Return-1.11%
Asset-MV
Value-0.50
Score0/3
Weight11.48%
1M Return5.75%
Value-0.50
Score0/3
Weight11.48%
1M Return5.75%
Total operating revenue (YoY growth rate %)
Value-99.75
Score2/3
Weight1.72%
1M Return1.11%
Value-99.75
Score2/3
Weight1.72%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight16.08%
1M Return8.45%
Value0.46
Score2/3
Weight16.08%
1M Return8.45%
PB-ROE
Value0.19
Score3/3
Weight21.80%
1M Return12.83%
Value0.19
Score3/3
Weight21.80%
1M Return12.83%
Operating revenue (YoY growth rate %)
Value-99.75
Score2/3
Weight0.66%
1M Return0.43%
Value-99.75
Score2/3
Weight0.66%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight15.81%
1M Return8.41%
Value-0.07
Score2/3
Weight15.81%
1M Return8.41%
Revenue-MV
Value-6.96
Score3/3
Weight20.17%
1M Return10.54%
Value-6.96
Score3/3
Weight20.17%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value-99.75
Score2/3
Weight1.72%
1M Return1.11%
Value-99.75
Score2/3
Weight1.72%
1M Return1.11%
Days sales outstanding
Value1700.16
Score1/3
Weight-2.22%
1M Return-1.57%
Value1700.16
Score1/3
Weight-2.22%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight16.08%
1M Return8.45%
Value0.46
Score2/3
Weight16.08%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight16.10%
1M Return8.45%
Value-0.17
Score2/3
Weight16.10%
1M Return8.45%
PB-ROE
Value0.19
Score3/3
Weight21.80%
1M Return12.83%
Value0.19
Score3/3
Weight21.80%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.61%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.61%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value-99.75
Score2/3
Weight0.66%
1M Return0.43%
Value-99.75
Score2/3
Weight0.66%
1M Return0.43%
Asset-MV
Value-0.50
Score0/3
Weight11.48%
1M Return5.75%
Value-0.50
Score0/3
Weight11.48%
1M Return5.75%
Cash-MV
Value-0.07
Score2/3
Weight15.81%
1M Return8.41%
Value-0.07
Score2/3
Weight15.81%
1M Return8.41%
Is CNTB fundamentally strong?
- CNTB scores 4.19/10 on fundamentals and holds a Fair valuation at present. Backed by its -54.73% ROE, -6466.80% net margin, -2.75 P/E ratio, 2.45 P/B ratio, and 0.00% earnings growth, these metrics solidify its Netural investment rating.
